loader2
Partner With Us NRI

Company details

1.61
1.74
1.16
1.74
6M Return 0.00%
1Y Return 56.76%
Mkt Cap.(Cr) 3.33
Volume 75,150
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 75,150

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 3.95 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 1,077.60 36,508.33
LAST 3M 37,266.27 17,620.78
LAST 6M 119,602.74 -141,271.72
LAST 12M 212,222.92 -215,172.33

Information

  • About Company
  • Company Info
  • Listing Info
0
35.89%
1.9995
0%
0%
Description
  • Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical, generic, and over the counter drugs in various formulations. The company`s generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic, antipyretic, and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi, India. It also markets its products in the Middle East, South America, and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997. In his leadership, the company has witnessed a fast growth rate, without compromise to quality. During the year 2003-2004, the company established their brand, Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005, the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa, Robial, Chewfe-C, Stibomin, Wibatol, Wibatol-O, Twosum, and Arfagel. During the year 2005-2006, the company bagged Govt. supply contracts from Govt. of Andhra Pradesh and Kerala Govt. for supply of Paracetamol. The company executed both the contracts on time. During the year 2007-2008, the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level.

Read More

Registered Address

138 Roz-Ka-Meo Industrial Area, Sohna, Mewat, Haryana, 122103

Tel : 91-124-2362471/2014471
Email : mail:advikindia.com
Website : http://www.advikindia.com

Registrar

Beetal Fin.&Computer Ser.P Ltd

AGM Date (Month) : Dec
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531686
NSE Code :
Book Closure Date (Month) : Dec
BSE Group : XT
ISIN : INE537C01019

ICICIdirect Advik Laboratories Ltd FAQ

You can buy Advik Laboratories Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advik Laboratories Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Aug 16, 2022 04:01 PM the closing price of Advik Laboratories Ltd was ₹ 1.74.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Aug 16, 2022 04:01 PM, the market cap of Advik Laboratories Ltd stood at ₹ 3.33.
The latest PE ratio of Advik Laboratories Ltd as of Aug 16, 2022 04:01 PM is 0
The latest PB ratio of Advik Laboratories Ltd as of Aug 16, 2022 04:01 PM is 1.15
The 52-week high of Advik Laboratories Ltd is ₹ 1.74 while the 52-week low is ₹ 1.16 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE